PE firm ChrysCapital-backed Mankind Pharma which intends to raise Rs 4500-4700 crore from the initial public offering (IPO) is opening for subscription on April 21.
The issue will close on April 25 and list on the NSE and BSE on May 4.
As per DRHP, the issue comprises only offer for sale component where Ramesh Juneja, Rajeev Juneja and sheetal Arora are the promoters offloading their shares. While Cairnhill CIPEF Limited, Cairnhill CGPE Limited, Beige Limited, and Link Investment Trust are the investors selling their shareholding. A total of 40,058,844 equity shares will be available for subscription.
Hence, the company will not receive any proceeds from the IPO.
Mankind Pharma has not yet disclosed the issue price of the IPO.
Kotak Mahindra Capital, Axis Capital, IIFL Capital Services, Jefferies India, and J.P. Morgan India are the merchant bankers of the IPO. KFin Technologies Limited is the registrar of the issue.
Mankind Pharma IPO important details
| Open date | April 21 |
| Close date | April 25 |
| Lot size | NA |
| IPO size (Rs crore) | NA |
| IPO price range (Rs) | NA |
| Minimum investment | NA |
| Basis of allotment date | April 28 |
| Refunds date | May 2 |
| Credit to demat account date | May 3 |
| Listing date | May 4 |
.png)
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
